In a recent study, CMG2 was identified to be capable of co-activating a Wnt/b-catenin pathway via LRP6 binding in gastric cancer cells, thus triggering the maintenance of a stem cell-like phenotype associated with the capability of epithelial-mesenchymal transition (EMT) and high metastatic abilities [33]. The gene discussed is LRP6; the disease is gastric cancer.